Loading data
CMCONasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 1.19 bn USD | 963.03 m USD | 1.01 bn USD | 936.24 m USD | 906.56 m USD |
| Cost of revenue | 834.02 m USD | 637.35 m USD | 638.7 m USD | 594.14 m USD | 590.83 m USD |
| Gross profit | 359.43 m USD | 325.68 m USD | 374.84 m USD | 342.1 m USD | 315.73 m USD |
| Research and development expense | 21.41 m USD | 23.87 m USD | 26.19 m USD | 20.94 m USD | 15.35 m USD |
| Operating profit | -119.33 m USD | 54.57 m USD | 107.15 m USD | 97.84 m USD | 73.78 m USD |
| Profit before tax | -206.51 m USD | -5.51 m USD | 61.53 m USD | 74.48 m USD | 38.45 m USD |
| Income tax expense | 22.93 m USD | -367 k USD | 14.9 m USD | 26.05 m USD | 8.79 m USD |
| Net income (reported basis) | -229.54 m USD | -5.14 m USD | 46.63 m USD | 48.43 m USD | 29.66 m USD |
| Net income attributable to common shareholders | -212.49 m USD | -5.14 m USD | 46.63 m USD | — | — |
| Basic earnings per share | -7.4 USD/share | -0.18 USD/share | 1.62 USD/share | 1.69 USD/share | 1.06 USD/share |
| Diluted earnings per share | -7.4 USD/share | -0.18 USD/share | 1.61 USD/share | 1.68 USD/share | 1.04 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.